Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹7.31 Cr₹10 Cr--₹0.83 Cr

What is the latest Capital Work in Progress ratio of BAFNA PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of BAFNA PHARMACEUTICALS is ₹7.31 Cr based on Mar2025 Standalone results.
Year Capital Work in Progress
Mar2025₹7.31 Cr
Mar2024₹10 Cr
Mar2023-
Mar2022-
Mar2021₹0.83 Cr

How is Capital Work in Progress of BAFNA PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹7.31 Cr
-30.33
Mar2024 ₹10 Cr
0
Mar2023 -
0
Mar2022 -
-100.00
Mar2021 ₹0.83 Cr -

Compare Capital Work in Progress of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹292.7 Cr 0.7% -11.8% 54.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

0.7%

-11.8%

54.6%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses